Clinical Evidence
Linking Hypothermia and Hyperglycemia
Setting: 571-bed acute care hospital (named among Top 100 cardiovascular hospitals in U.S.).
Objective
This case study examines the impact of using a computer-guided glucose management software system (EndoTool) for post-cardiac arrest patients undergoing induced hypothermia, a therapy with known risks of decreased insulin secretion and insulin sensitivity.
Setting
571-bed acute care hospital (named among Top 100 cardiovascular hospitals in U.S.).
Results
- With traditional paper protocols, intravenous insulin titration required complex manual calculations and overall glucose control was inadequate, often including hyperglycemia followed by hypoglycemia.
- With EndoTool, calculations for intravenous insulin titration were made by the system, nurses noted that glucose levels were quickly controlled, and there were no hypoglycemia events.
Conclusions
Use of a computer-guided glucose management software system (EndoTool) for intravenous insulin titration delivers demonstrably better outcomes than traditional paper protocols for patients undergoing induced hypothermia.
References
Authors
Tracey Melhuish, RN, MSN.
Source
Published in Nursing Management, Volume 40, Issue 12, p42-45.
Year
2009
Related posts
Clinical Evidence
Near Elimination of Severe Hypoglycemia with EndoTool IV Across a 19-Hospital Health System
Near Elimination of Severe Hypoglycemia with EndoTool IV Across a 19-Hospital Health System
To evaluate the impact of EndoTool IV insulin dosing software on reducing severe hypoglycemia (SH) (blood glucose < 40 mg/dL) across 19-hospitals at a prominent health system, including outcomes in patients with renal insufficiency.

Clinical Evidence
Temple Health Achieves Zero Severe Hypoglycemia in Renally Impaired Patients with EndoTool SubQ
Temple Health Achieves Zero Severe Hypoglycemia in Renally Impaired Patients with EndoTool SubQ
To evaluate the safety and efficacy of the EndoTool SubQ (ETSQ) insulin dosing application for subcutaneous (SQ) insulin administration in hospitalized patients, and to compare clinical outcomes against those treated using a standard insulin order set. The analysis also examined performance in high-risk patients with advanced renal impairment.

Clinical Evidence
Improving Inpatient Glycemic Safety at Temple Health with EndoTool SubQ
Improving Inpatient Glycemic Safety at Temple Health with EndoTool SubQ
Temple Health, a 3-hospital academic system was experiencing high rates of hypoglycemia due to reliance on sliding scale insulin (SSI). To improve safety and align with ADA guidelines, the hospital implemented EndoTool SubQ, a patient-specific insulin dosing software the supports four dosing protocols, including basal-bolus-correction (BBC).
Get in Touch
Ready to get started?
Fill in your details and one of our friendly team members will be in touch to show you how easily EndoTool can support your hospital.
"*" indicates required fields
